Physician profile
Christopher P Meyer
NPI 1669585816
$3,647.91
in general payments reported to CMS, 2019-2025
7 companies · $356 in 2025
The $356 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.33 · 2021: $1,359 · 2022: $452 · 2023: $1,460 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $967 · Food and Beverage: $747 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $967.29 |
| Food and Beverage | $746.72 |
| Education | $101.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,155.15 | 2019-2025 | Rosa, Persona, Oss Orthopedic Salvage System |
| Conformis, INC. | $1,246.20 | 2021 | |
| Medtronic, INC. | $148.75 | 2025 | Aquamantys(Tm) |
| Depuy Synthes Sales INC. | $56.50 | 2023 | |
| Stryker Corporation | $21.05 | 2023 | Mako |
| Medical Device Business Services, INC. | $20.26 | 2025 | Velys |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,041,635.84 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.